Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Orbit ; 28(6): 371-6, 2009.
Article in English | MEDLINE | ID: mdl-19929662

ABSTRACT

AIMS/PURPOSE: Spheno-orbital meningiomas account for 9% of all adult intracranial meningiomas. Complete resection is extremely difficult with this condition. We report on our experience in the surgical management of spheno-orbital meningiomas. METHODS: A retrospective review was performed of all patients with spheno-orbital meningiomas who underwent joint neurosurgical and ophthalmic procedures between January 2000 and December 2007. Radiological findings, presenting clinical signs, indications for surgery, surgical approach, histopathological findings, surgical complications and post-operative results were recorded. RESULTS: Twelve patients were included in the study. Visual function deterioration was the main indication for surgery. Six patients underwent an optic canal decompression along with their initial tumour resection and all 12 patients underwent an extensive lateral orbital wall decompression. Post-operatively 6 patients had reduced proptosis. Two patients had an improvement in their visual acuity, 5 patients had a stable visual acuity and 5 patients had a progressive deterioration in visual acuity following surgery. Six patients maintained a stable visual field. Cranial nerve palsy was the commonest post-operative complication. Three patients required postoperative fractionated radiotherapy. Three patients required further surgery. CONCLUSION: Spheno-orbital meningiomas are difficult tumours to manage. Surgical resection can reduce the degree of proptosis and stabilise visual function in patients with failing vision, although sustained improvement is difficult to achieve if the tumour behaves in an aggressive manner. The risk of post-operative visual loss is considerable, either due to surgery or tumour progression. Outcomes from surgical decompression may not necessarily be better than the natural history of these tumours.


Subject(s)
Meningioma/surgery , Neurosurgical Procedures , Ophthalmologic Surgical Procedures , Orbital Neoplasms/surgery , Skull Neoplasms/surgery , Sphenoid Bone/surgery , Adult , Female , Humans , Magnetic Resonance Imaging , Male , Meningioma/diagnostic imaging , Meningioma/pathology , Middle Aged , Orbital Neoplasms/diagnostic imaging , Orbital Neoplasms/pathology , Patient Care Team , Retrospective Studies , Skull Neoplasms/diagnostic imaging , Skull Neoplasms/pathology , Sphenoid Bone/diagnostic imaging , Tomography, X-Ray Computed , Treatment Outcome , Visual Acuity
2.
Neurosurgery ; 65(1): E210-1; discussion E211, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19574803

ABSTRACT

OBJECTIVE: Thorotrast was used as a contrast medium in clinical practice until the 1960s for outlining cerebral abscess cavities and ventricular cavities, and for angiography. Gliosarcomas, meningiomas, and schwannomas have been reported previously, as has Thorotrast-associated angiosarcoma, typically in the liver. A unique case of a primary intracerebral well-differentiated angiosarcoma in a 68-year-old man with a history of colocalized exposure to Thorotrast is described. This may be the first case of a primary angiosarcoma in the brain. CLINICAL PRESENTATION: The patient presented with a progressive left-sided weakness 62 years after initial surgery for a right parietal cerebral abscess, which included the instillation of Thorotrast into the abscess cavity. Computed tomography showed a right parietal tumor. INTERVENTION: An explorative craniotomy showed an intrinsic, infiltrating, very vascular tumor with surrounding calcification. The tumor appeared to arise from a benign cavernous vasoformative lesion intimately associated with a Thorotrast-type granuloma. The patient declined further surgery or radiotherapy. CONCLUSION: The histology, confirmation of radioactivity of the material obtained from within the tumor, and latency period of presentation provide compelling support for tumor induction by the Thorotrast. Primary lesions of the central nervous system associated with Thorotrast are very rarely reported, despite its extensive use in cerebral angiography and management of brain abscess between 1930 and 1960.


Subject(s)
Brain Neoplasms/chemically induced , Carcinogens/pharmacology , Hemangiosarcoma/chemically induced , Hemangiosarcoma/diagnosis , Thorium Dioxide/pharmacology , Aged , Brain Neoplasms/diagnosis , Brain Neoplasms/surgery , Cerebral Angiography , Cerebral Cortex/pathology , Cerebral Cortex/surgery , Hemangiosarcoma/surgery , Humans , Male , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...